|  | 
                     Ectopic ureter occurs in only 0.025% of the population. Approximately 10% are bilateral 
                    with a 6:1 female to male ratio.1 In females, more than 80% of ectopic ureter drains duplicated systems. In 
                    males, it mostly drains a single system. In males, the ureter may terminate at 
                    the bladder neck (48%), seminal vesicle (40%), ejaculatory duct (8%), vas 
                    deferens (3%), or epididymis (0.5%). In females, the ureter may terminate at the 
                    bladder neck (35%), vestibule (30%), vagina (25%), or uterus (5%).1 
                    When present, ectopic ureter can be associated with duplex kidneys in 85% of the 
                    cases. Clinical manifestations of this malformation include incontinence and 
                    urinary tract infections.2 Ectopic termination of the ureter is the 
                    result of the high (cranial) origin of the ureteral bud from the mesonephric 
                    duct. The delayed incorporation of the ureteral bud into the bladder results in 
                    ureteral orifice to be more caudal and medial. A sufficient tunnel length of the 
                    sub mucosal ureter is the most important component of Vesico ureteic obstruction 
                    (UVJ). Being asymptomatic, most children present with an abnormal finding on 
                    routine prenatal ultrasound. Some patients present with urinary tract infection 
                    (UTI), cyclic abdominal pain, abdominal mass, and hematuria. Other presentations 
                    include hypertension, proteinuria, or even renal insufficiency. Approximately 
                    50% of females present with constant urinary incontinence or vaginal discharge.  
                 
                    A 3 months old Caucasian female was presented at the age of two months following her 
                    routine vaccination. She became lethargic and feeding poorly. She was admitted to a private hospital where her initial 
                    blood electrolytes showed subtle changes of hyponatremia and hyperkalemia, which 
                    settled following intravenous fluid infusion (0.45Nacl with 5%D). Antibiotics 
                    were initially administered empirically and discontinued at 48 hrs after 
                    negative urine culture reports. She was discharged home on the fifth day. At 3 
                    months old, she developed similar symptoms and was admitted to the pediatrics 
                    unit, Mafraq Hospital. Her weight gain was satisfactory, but very recently her 
                    parents noticed a weight lag. She was born from non consanguineous parents by caesarean section; indication 
                    being previous sections. On the fetal anomaly scan conducted at 20 weeks of 
                    gestation, the left kidney was found to be slightly larger than the right one. 
                    But there was no follow up scan. The baby was born at term weighing 2.5 Kg. The 
                    neonatal period was uneventful. No congenital anomaly was noted. After the 
                    initial few days of breast feeding, bottle feeding was commenced. While admitted 
                    to the pediatrics unit, the patient looked lethargic. Her heart rate was 
                    110/min, respiratory rate was 36/min and capillary refill was less than 2 
                    seconds. She was apyrexial with mild to moderate dehydration. Her blood pressure 
                    was 113/64 and both femoral pulses were palpable. Systemic examinations were 
                    normal with normal genitalia. Serum electrolytes revealed 120meq/l of sodium and 
                    8.4meq/l of potassium. She was 
                    resuscitated with normal saline and also received simultaneous treatment for 
                    hyperkalemia. After the initial resuscitation, her serum potassium dropped to 
                    7.5meq/l but she remained hyponatremic (119meq/l). 
                 
                     There was normal anionic gap and compensated metabolic acidosis. Urinary sodium, 
                    chloride, potassium and calcium were abnormally high. All these features were 
                    denoting renal tubular acidosis type 4; relative inadequacy of serum 
                    aldosterone. Serum urea and creatinine were initially slightly raised but brisk 
                    improvement on IV fluids suggesting dehydration was the possible explanation. 
                    Her leukocyte count was 29,000/dl with neutrophil predominance; Hb was 97 gm/l, 
                    Platelets count was 250000/dl, C-reactive protein was 51 mg/l and Procalcitonine 
                    level was suggestive of systemic bacterial infection. Urinalysis showed high 
                    protein with protein creatinine ratio of 2.09. Urine was full of pus cells, and 
                    was positive for bacteria and nitrites. Serum hormone levels such as cortisol, 
                    Dyhydroepiandrosterone acetate (DHEA), adrenocorticotropic hormone (ACTH), 
                    17-OH-progesterone, androstendione, thyroxin, all were within normal range. Her 
                    serum aldosterone level was very high (more than 2744 IU/l), confirming PHA.    
                 
                     Initial 
                    renal ultrasound scan showed normal right kidney and ureter. Her left kidney was 
                    enlarged and there was grossly dilated left ureter with debris suggesting 
                    pyelonephritis. The bladder was compressed by the grossly dilated left ureter. 
                    Both the ureters were abnormally inserted to the bladder at a lower level, right 
                    one being just distal to neck of the bladder into the urethra. Surprisingly, 
                    there was no evidence of any dribbling. Intravenous cefotaxime was commenced for 
                    E-coli urinary tract infection. MAG3 scan confirmed normal functioning right 
                    kidney, moderate impairment of function of the enlarged left kidney with 
                    hydronephrotic changes, hydroureter and evidence of organic obstructive uropathy 
                    at the left VUJ with abnormal insertion to the bladder (Fig. 1). Initial 
                    management was conducted with adequate saline infusion and correcting 
                    hyperkalemia with sodium bicarbonate, salbutamol nebulisation, resonium salts 
                    and calcium infusion. Later, the patient was kept on oral sodium supplements (15 
                    mmol per day) maintaining normal electrolytes. She underwent left ureterostomy 
                    operation to facilitate the drainage. Postoperatively, she had another episode 
                    of UTI and was treated with intravenous Meropenem. At 4 weeks follow up, her 
                    electrolytes remained normal and serum Aldosterone level resumed normal range.  
 
  
 
  
 
                   The patient was then planned for reconstructive surgery for
reinsertion of both ureters which was conducted after 6 months of
the primary procedure.
                 
                The electrolyte imbalance presenting early in life is a matter of
emergency, as life threatening conditions like congenital adrenal
hyperplasia can present similarly. Congenital adrenal hyperplasia
(CAH) should be considered in all neonates with hyponatremia
coupled with hyperkalemia. Therefore, presumptive diagnosis
  
                    of CAH was made in this case and hydrocortisone was started pending the hormonal study. 
                    The history of renal size disparity noted in the antenatal period was suggestive 
                    of renal pathology. Most structural anomalies of renal calyces noted at 20 weeks 
                    of gestation tend to be corrected spontaneously.3  
                 
                     The effects of urinary tract obstruction on the developing kidney depend on the time of 
                    onset, location, and degree of obstruction. Ureteral obstruction during early 
                    pregnancy results in dysplasia of the renal parenchyma and a reduction in the 
                    number of nephrons. Partial or complete ureteral obstruction in neonates causes 
                    renal vasoconstriction, glomerular hypoperfusion, impaired ipsilateral renal 
                    growth, and interstitial fibrosis. The recovery of renal function after relief 
                    of urinary tract obstruction is related to age.4 During complete 
                    ureteral obstruction, renal blood flow progressively decreases. Renal blood flow 
                    is 50% of normal after 24 hours, 30% at 6 days, 20% at 2 weeks, and 12% at 8 
                    weeks.3 After ureteral obstruction, there is a rapid influx of 
                    macrophages and suppressor T lymphocytes in the cortex and medulla and increased 
                    urinary thromboxane A2, as well as a decrease in the glomerular filtration rate.5 
                    The production of thromboxane A2 by the infiltrating macrophages contributes to 
                    the renal vasoconstriction and poor medullary blood flow. After the release of 
                    the obstruction, the cellular infiltration is slowly reversible, requiring 
                    several days to revert to near normal levels.5  
                 
                     The history of admission of the baby in another private hospital with subtle changes in 
                    electrolytes which reversed in few days of saline infusion was indicative of 
                    hypoaldosteronism. The aldosterone resistance form of RTA type IV was another 
                    possibility.  
                 
                    The Aldosterone resistance state, also known as PHA has been coined to describe 
                    disorders of electrolyte homeostasis characterized by a condition of renal 
                    tubular lack of sensitivity to aldosterone. There are two subtypes. Type I is a 
                    hereditary disorder related to the loss of function of the mineralocorticoid 
                    receptor. In recent years, it has become clear that type 1 PHA is a 
                    heterogeneous syndrome that includes at least two clinically and genetically 
                    distinct entities with either renal or multiple target-organ defects.6 
                    While Type II is described as pseudohypoaldosteronism (PHA2), also recognized as 
                    Gordon’s Syndrome, it is thought to be a primary renal secretory defect that 
                    results from enhanced chloride reabsorption and consequent hyperkalemia, 
                    metabolic acidosis, and low-renin arterial hypertension. The normal serum 
                    chloride level in this patient was not in favor of this diagnosis.6  
                     Renal PHA1 represents the most frequent form of primary PHA and is related to the loss 
                    of function of the mineralocorticoid receptor. The mode of inheritance is 
                    autosomal dominant with variable expression, although many cases appear as 
                    sporadic. The reasons for phenotype differences are unknown, but they may be 
                    related to intercurrent volume-depleting events or to dietary habits of salt 
                    ingestion during life. In addition, the coexistence of polymorphism or mutations 
                    in the gene encoding epithelial sodium channel could play a potential role.  
                 
                     The severity of clinical and laboratorial manifestations at the time of the diagnosis 
                    is inversely correlated to the age of the patient, ranging from a neonatal 
                    life-threatening salt wasting syndrome to an adult asymptomatic elevation of 
                    plasma aldosterone levels. In the studied case, further investigation revealed 
                    obstructive uropathy as the original cause of the type IV RTA and 
                    pseudohypoaldosteronism. Bilateral obstructive uropathy is a well known cause of 
                    RTA type IV and PHA because of insensitivity of the aldosterone to the tubules. 
                    Acute pyelonephritis in the presence of urinary tract anomalies increases the 
                    risk of PHA, although both factors independently can cause aldosterone 
                    unresponsiveness.7  
                 
                     Unilateral renal tubular unresponsiveness to aldosterone should not cause any 
                    electrolyte imbalance because of the normal functioning of the opposite kidney. 
                    In this case, the obstruction is unilateral in the presence of PHA, left us to 
                    two possibilities. Firstly, this may purely be a coincidence of type I PHA with 
                    a concordant association of unilateral VUJ obstruction and bilateral ectopic 
                    ureters. The second possibility was that in the presence of unilateral 
                    obstruction, there was also super added pyelonephritis, both of which were 
                    contributing together to produce transient secondary aldosterone insensitivity.  
                 
                    No genetic test was carried out for the PHA I and PHA II. However, as the condition 
                    disappears following the relieving the obstruction and treating the infection, 
                    it is the second possibility which is most likely. 
                 
                    The take-home message from this case is to appreciate the common occurrence of ureteral 
                    anomalies and the uncommon presentation of electrolyte disturbances because of 
                    the ectopic ureter. A very high index of suspicion is required to rule in or out 
                    the possibility of renal tract anomaly when there is abnormality of electrolytes 
                    in the body, particularly if it is persistent and/ or recurrent. This case 
                    identified the rare presentation of the relatively common anomalies of the human 
                    body. It is also a very good example for assurance that this hormonal change is 
                    transient and can be corrected on its own when the obstruction is relieved and 
                    infection is controlled. ACKNOWLEDGEMENTS 
 
       The authors reported no conflict of interest and no funding was received on this work
               
                     REFRENCES 
 
                
         
                         
                     
                              Husmann DA. Ureteral Ectopy, 
                             Ureteroceles, and Other Anomalies of the Distal Ureter. In: Gonzales ET, Bauer 
                             SB, eds. Pediatric Urology Practice. Philadelphia, Pa: Lippincott Williams & 
                             Wilkins;. 1999:295. 
                              Mart?n MS, Garc?a-Ripoll TJ, Ru?z SA, Rodr?guez GV, Ferro RJ, del Busto FE. 
                              Ectopic ureter as cause of pyonephrosis and urinary incontinence .Actas Urol 
                              Esp. 2008 Feb; 32(2):256-260. Spanish 
                               Shukla AR, Cooper J, Patel RP, Carr MC, Canning DA, Zedric SA, et 
                              al. Prenatally detected primary megaureter: a role for extended followup. J 
                              Urol. Apr 2005;173(4):1353-1356. 
                               Chevalier RL: Effects of ureteral obstruction on renal growth. Semin Nephrol 
                              1995; 15:353-360. 
                              Schreiner GF, Harris KPG, Purkerson ML, Klahr S: Immunological aspects of 
                              acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int 
                              1988; 34:487-493. 
                                Komesaroff PA, Verity K, Fuller PJ. Pseudohypoaldosteronism: molecular 
                              characterization of the mineralocorticoid receptor. J Clin Endocrinol Metab. 
                              1994 July; 79(1):27-31. 
                               Melzi ML, Guez S, Sersale G. Acute pyelonephritis as a cause of hyponatremia/ 
                              hyperkalemia in young infants with urinary tract malformations. Pediatr Infect 
                              Dis J. 1995 Jan; 14(1):56-59. |  |